Randomized Comparison of Ridaforolimus- and Zotarolimus-Eluting Coronary Stents in Patients With Coronary Artery Disease: Primary Results From the BIONICS Trial (BioNIR Ridaforolimus-Eluting Coronary Stent System in Coronary Stenosis).

Kandzari, David E

Randomized Comparison of Ridaforolimus- and Zotarolimus-Eluting Coronary Stents in Patients With Coronary Artery Disease: Primary Results From the BIONICS Trial (BioNIR Ridaforolimus-Eluting Coronary Stent System in Coronary Stenosis). [electronic resource] - Circulation Oct 2017 - 1304-1314 p. digital

Publication Type: Journal Article; Randomized Controlled Trial

1524-4539

10.1161/CIRCULATIONAHA.117.028885 doi


Coronary Artery Disease--therapy
Drug-Eluting Stents--standards
Female
Humans
Male
Percutaneous Coronary Intervention--methods
Prospective Studies
Sirolimus--administration & dosage